IMC Chicago’s Vaxart VXRT Stock Holding History

IMC Chicago’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-34,913	Closed	-$238K	–	1335
2021 Q3	$278K	Buy	34,913 +8,254	+31%	+$67.9K	﹤0.01%	1163
2021 Q2	$200K	Buy	+26,659	New	+$186K	﹤0.01%	1091

Other funds holding VXRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

IMC Chicago's VXRT Position: Q4 2021 in Review

IMC Chicago sold out of Vaxart (VXRT) in Q4 2021, closing a stake of 34,913 shares — an estimated $238K sold.

IMC Chicago first reported a position in VXRT in Q2 2021 and held it in 2 quarters. The position peaked at $278K in Q3 2021. 147 funds tracked by Wall St. Rank hold VXRT as of Q4 2021.

IMC Chicago reported no remaining Vaxart position as of Q4 2021 after selling out during the quarter.
IMC Chicago sold 34,913 Vaxart shares in Q4 2021, an estimated $238K.
IMC Chicago first reported a position in Vaxart in Q2 2021 and held it in 2 quarters.
IMC Chicago's Vaxart position peaked at $278K in Q3 2021.
147 funds tracked by Wall St. Rank held Vaxart as of Q4 2021.

Based on IMC Chicago's 13F filing for Q4 2021, filed 8 Feb 2022.